Primate Toxoplasmosis Study Guide

Overview and Clinical Importance

Toxoplasmosis is a potentially fatal multisystemic protozoal disease caused by Toxoplasma gondii. This disease is of critical importance in captive primate management and represents a high-yield topic for the NAVLE exam. New World primates (NWP) are exceptionally susceptible to fulminant toxoplasmosis, with mortality rates approaching 100 percent in some species if untreated, while Old World primates (OWP) are relatively resistant to clinical disease.

Toxoplasmosis is one of the most common causes of death in captive New World primates and can present as sudden death without premonitory signs or as acute multisystemic disease. Understanding the epidemiology, clinical presentation, and management of this disease is essential for veterinary practitioners working with exotic species.

Etiology and Life Cycle

The Causative Agent

Toxoplasma gondii is an obligate intracellular protozoan parasite belonging to the phylum Apicomplexa. It is one of the most successful parasites worldwide, capable of infecting virtually all warm-blooded animals including birds and mammals. The parasite has a complex life cycle involving both sexual and asexual reproduction.

Life Cycle Stages

Tachyzoites: The rapidly dividing, crescent-shaped form (4-8 micrometers long by 2-3 micrometers wide) characteristic of acute infection. Tachyzoites multiply asexually within host cells and disseminate throughout the body, causing tissue damage and clinical disease.

Bradyzoites: The slowly dividing form found within tissue cysts. These develop 7-10 days post-infection and persist for the life of the host, primarily in neural and muscle tissue. Bradyzoite-containing cysts can reactivate under immunosuppression.

Sporozoites: Contained within oocysts, these are the product of sexual reproduction occurring only in the intestinal epithelium of felids (definitive hosts). Each oocyst contains two sporocysts, each with four sporozoites.

Definitive and Intermediate Hosts

Definitive hosts: Members of the family Felidae (domestic cats, wild felids) are the only animals capable of supporting sexual reproduction of T. gondii. After ingesting tissue cysts or oocysts, cats shed millions of unsporulated oocysts in feces for 1-3 weeks following primary infection. Oocysts sporulate in the environment within 1-5 days and remain infective for up to one year in suitable conditions.

Intermediate hosts: All warm-blooded animals, including primates, serve as intermediate hosts. Infection occurs through ingestion of sporulated oocysts (from contaminated water, soil, food) or tissue cysts in undercooked meat.

Species Susceptibility and Epidemiology

New World Primates - High Susceptibility

New World non-human primates (NWNHP) from Central and South America are exceptionally susceptible to clinical toxoplasmosis with high mortality rates. This group includes:

Callitrichids: Marmosets (Callithrix spp.), tamarins (Saguinus spp., Leontopithecus spp.) - extremely susceptible, often die suddenly

Cebids: Squirrel monkeys (Saimiri sciureus) - considered the MOST susceptible species, capuchins (Cebus spp.), howler monkeys (Alouatta spp.)

Atelids: Spider monkeys (Ateles spp.), woolly monkeys (Lagothrix spp.)

In captive settings, mortality from toxoplasmosis can reach 90-100 percent in susceptible New World primate species. Death may occur within 3-10 days of infection, often with minimal or no premonitory clinical signs.

Old World Primates - Relative Resistance

Old World non-human primates (OWNHP) from Africa and Asia show relative resistance to clinical toxoplasmosis. These include macaques (Macaca spp.), baboons (Papio spp.), and great apes. While seroprevalence can be high (indicating exposure), clinical disease is rarely reported in immunocompetent Old World primates.

Exam Focus: NEW = VULNERABLE NEW World primates (from the NEW World - Americas) are NEWLY vulnerable to toxoplasmosis OLD World primates (from the OLD World - Africa/Asia) have OLD immunity and are resistant Squirrel monkeys = SUPREME susceptibility (most susceptible of all NWP)

Pathophysiology and Pathology

Route of Infection

Primates become infected primarily through:

1. Ingestion of sporulated oocysts: from contaminated water, soil, vegetation, or food exposed to feline feces. This is the most common route in captive primates.

2. Ingestion of tissue cysts: in undercooked or raw meat (less common in managed settings).

3. Congenital transmission: transplacental transmission from acutely infected mothers (rare but documented).

Pathogenesis in Susceptible Species

After ingestion, bradyzoites or sporozoites are released in the gastrointestinal tract, where they invade intestinal epithelial cells and differentiate into tachyzoites. Tachyzoites rapidly multiply and disseminate hematogenously and lymphatically throughout the body.

The marked susceptibility of New World primates is hypothesized to be due to an inadequate cell-mediated immune response, particularly insufficient interferon-gamma (IFN-?) production, which is critical for controlling tachyzoite multiplication. This allows unchecked parasite replication and overwhelming tissue destruction.

Gross and Microscopic Pathology

Most Commonly Affected Organs:

Clinical Signs and Presentation

Acute Fulminant Toxoplasmosis

Approximately 44 percent of affected New World primates die without apparent clinical signs (peracute death). Animals are found dead or moribund with a history of being normal the previous day.

Common Clinical Signs (when present)

Clinical Course: When clinical signs are present, disease progresses rapidly. Most affected animals die within 3-10 days of onset of clinical signs despite treatment attempts.

Diagnosis

Antemortem Diagnosis

Antemortem diagnosis is extremely challenging due to the peracute nature and rapid progression of disease. However, when suspicion exists:

1. Serology: Detection of Toxoplasma-specific antibodies (IgG, IgM)

IgM antibodies indicate recent/acute infection

IgG antibodies indicate chronic or past infection

Modified Agglutination Test (MAT) or Direct Agglutination Test (DAT) commonly used

Limitation: Many NWP die before seroconversion occurs

2. PCR (Polymerase Chain Reaction): Detection of T. gondii DNA in blood, CSF, or tissue samples

Highly sensitive and specific

Can detect parasitemia before seroconversion

Real-time PCR allows quantification of parasite load

3. Clinical Pathology: Non-specific changes may include:

Leukopenia or leukocytosis

Elevated liver enzymes (ALT, AST)

Hyperbilirubinemia

Hypoalbuminemia

Postmortem Diagnosis

Postmortem diagnosis is most commonly how toxoplasmosis is confirmed in NWP:

1. Histopathology (Gold Standard): Identification of tachyzoites and/or tissue cysts in tissue sections

Tachyzoites: crescent or oval-shaped, 4-8 × 2-3 micrometers

Best visualized with Giemsa, Wright-Giemsa, or H&E stains

Tissue cysts: round to oval structures containing numerous bradyzoites

2. Immunohistochemistry (IHC): Uses antibodies against T. gondii antigens

Extremely helpful when organisms are sparse or tissue is necrotic

Provides definitive identification

3. PCR on Tissue: Molecular confirmation from fresh or frozen tissues

Treatment and Management

Treatment Challenges

Treatment success in New World primates is extremely limited due to the fulminant nature of disease and rapid progression. Most animals die despite aggressive treatment. However, early intervention may improve outcomes in some cases.

Antimicrobial Therapy

Key Principle: Currently available drugs target only the tachyzoite stage and do NOT eradicate encysted bradyzoites. No drugs eliminate tissue cysts.

Supportive Care

Fluid therapy: IV or SC fluids to maintain hydration and support blood pressure

Nutritional support: Force-feeding or tube feeding if anorexic

Oxygen therapy: For animals with dyspnea or pulmonary involvement

Warmth: External heat sources for hypothermic animals

Anti-inflammatory therapy: Corticosteroids may be considered in CNS disease (controversial - may worsen parasitemia)

Prevention and Biosecurity

Prevention is CRITICAL given the high mortality and limited treatment success in New World primates.

Environmental Management

1. Exclude cats from primate facilities: Prevent feline access to enclosures, food storage areas, and food preparation areas

2. Protect food and water: Cover food dishes, use filtered water, prevent contamination by wild animals

3. Proper food handling: Wash all produce thoroughly. Feed only commercially prepared or well-cooked meat products

4. Rodent control: Eliminate rodents which can harbor tissue cysts

5. Enclosure design: Use covered outdoor enclosures or indoor housing to prevent oocyst contamination from wild felids

Quarantine and Testing

Serologic screening: Test incoming primates for T. gondii antibodies during quarantine

Surveillance: Periodic serology in established colonies to monitor exposure

Prophylaxis: Some facilities use prophylactic TMP-SMX in high-risk situations (controversial)

Exam Focus: TOXO Prevention = NO CATS N = No cats near primates O = Oocyst prevention (covered food/water) C = Cover enclosures A = Avoid raw meat T = Test newcomers (serology) S = Sanitize produce

Public Health and Zoonotic Considerations

Zoonotic Potential: T. gondii can be transmitted from symptomatic NWP to humans through direct contact with body fluids, tissues, or contaminated surfaces. Personnel handling sick primates or performing necropsies should use appropriate personal protective equipment (PPE).

Safety Precautions:

• Gloves, gowns, and face protection when handling sick or dead primates

• Avoid aerosol generation during necropsy

• Pregnant women and immunocompromised individuals should avoid contact

• Proper disposal of carcasses and contaminated materials